THE GPR120 AGONIST TUG-891 AMELIORATES KIDNEY FIBROSIS AND INFLAMMATION IN DIABETIC NEPHROPATHY

Tiantian Wei,Liang Ma,Ping Fu
DOI: https://doi.org/10.1093/NDT/GFAA139.SO024
IF: 7.1857
2020-01-01
Nephrology Dialysis Transplantation
Abstract:Abstract Background and Aims ω3-Fatty acids (ω3FAs) attenuated inflammation, glomerulosclerosis and albuminuria in most experimental studies of diabetic nephropathy (DN). GPR120 has been identified as a first receptor for ω3FAs. Compared to ω3FAs, TUG-891 is a highly potent and selective agonist for GPR120. In this study, we examined the protective effects of GPR120 agonist TUG-891 in DN and investigated the possible mechanisms. Method Expression of GPR120 was detected in human renal biopsy tissue obtained from patients with early or advanced DN and in normal renal tissues. Effects of TUG-891 on the development of DN were investigated in male C57BLKS/J db/db mice and murine podocytes (MPC5). Expression of collagen IV, fibronectin, αSMA, TGF-β/smad2/3, IL-6, GPR120/β-arrestin2/TAK1 binding protein-1 and downstream pathways were measured. Results The expression of GPR120 was negatively correlated with the progression of DN. IF stainings showed that GPR120 was mainly expressed in podocytes of the glomerulus by co-localization of a special marker nephrin. In db/db mice, oral administration of TUG-891 significantly reduced urinary albumin excretion, improved podocyte injury and reduced collagen deposition in glomerulus. Meanwhile, TUG-891 inhibited the expression of fibronectin, collagen IV, α-SMA, TGF-β1 and IL-6, as well as down-regulated phosphorylation of Smad3 and STAT3 to alleviate the glomerulosclerosis. Mechanistically, TUG-891 effectively up-regulated the GPR120 expression in kidneys of db/db mice and HG-stimulated podocytes. TUG-891 also suppressed TAB1 expression and the phosphorylation of TAK1, IKKβ, NF-κB, JNK and p38 MAPK signals. Conclusion In summary, our result highlighted that TUG-891 ameliorated kidney fibrosis and inflammation by activating the intracellular GPR120 signaling pathway.
What problem does this paper attempt to address?